Skip to content

Clinical trials

Completed Schizophrenia trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Austria Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20052
20072
20083
20104
20113
20121
20131
20151
20161
20172
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.5
Janssen-Cilag International NV3
Alkermes, Inc.2
Boehringer Ingelheim2
Eli Lilly and Company2
Janssen Research & Development, LLC2
Medical University of Vienna2
AstraZeneca1
Denovo Biopharma LLC1
Haukeland University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia26
Psychotic Disorders7
Diabetes Mellitus1
Recurrence1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.